This site is archived and is no longer updated. It will be taken offline in mid-July. All the latest AWMSG recommendations, guidance and information is available on our new website at: https://awmsg.nhs.wales/.
awmsg logo



pitolisant (Wakix®)


Reference No. 2967

Publication date:
27/07/2016


Appraisal information

pitolisant (Wakix®) 4.5 mg film-coated tablet
pitolisant (Wakix®) 18 mg film-coated tablet


Company: Lincoln Medical Ltd
BNF category: Central nervous system
NMG meeting date: Not scheduled
AWMSG meeting date: Not scheduled
   
   
Submission Type: Nonsubmission
Status: Not endorsed
Advice No: Not available
Ratification by Welsh Government: 26/07/2016

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ratification by
Welsh Government

AWMSG advice

In the absence of a submission from the holder of the marketing authorisation, pitolisant (Wakix®) cannot be endorsed for use within NHS Wales in adults for the treatment of narcolepsy with or without cataplexy.
Statement of Advice (SOA)
Download